Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 5
2003 3
2004 1
2005 3
2006 3
2007 1
2008 1
2009 4
2010 1
2011 3
2012 7
2013 3
2014 3
2015 3
2016 1
2017 7
2018 3
2019 5
2020 9
2021 4
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

69 results
Results by year
Filters applied: . Clear all
Page 1
Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy.
Rayego-Mateos S, Morgado-Pascual JL, Opazo-Ríos L, Guerrero-Hue M, García-Caballero C, Vázquez-Carballo C, Mas S, Sanz AB, Herencia C, Mezzano S, Gómez-Guerrero C, Moreno JA, Egido J. Rayego-Mateos S, et al. Among authors: gomez guerrero c. Int J Mol Sci. 2020 May 27;21(11):3798. doi: 10.3390/ijms21113798. Int J Mol Sci. 2020. PMID: 32471207 Free PMC article. Review.
Animal models of cardiovascular diseases.
Zaragoza C, Gomez-Guerrero C, Martin-Ventura JL, Blanco-Colio L, Lavin B, Mallavia B, Tarin C, Mas S, Ortiz A, Egido J. Zaragoza C, et al. Among authors: gomez guerrero c. J Biomed Biotechnol. 2011;2011:497841. doi: 10.1155/2011/497841. Epub 2011 Feb 16. J Biomed Biotechnol. 2011. PMID: 21403831 Free PMC article. Review.
Atrasentan for the treatment of diabetic nephropathy.
Egido J, Rojas-Rivera J, Mas S, Ruiz-Ortega M, Sanz AB, Gonzalez Parra E, Gomez-Guerrero C. Egido J, et al. Among authors: gomez guerrero c. Expert Opin Investig Drugs. 2017 Jun;26(6):741-750. doi: 10.1080/13543784.2017.1325872. Expert Opin Investig Drugs. 2017. PMID: 28468519 Review.
Targeting inflammation in diabetic nephropathy: a tale of hope.
Moreno JA, Gomez-Guerrero C, Mas S, Sanz AB, Lorenzo O, Ruiz-Ortega M, Opazo L, Mezzano S, Egido J. Moreno JA, et al. Among authors: gomez guerrero c. Expert Opin Investig Drugs. 2018 Nov;27(11):917-930. doi: 10.1080/13543784.2018.1538352. Epub 2018 Oct 23. Expert Opin Investig Drugs. 2018. PMID: 30334635 Review.
Targeting chemokines in proteinuria-induced renal disease.
Moreno JA, Moreno S, Rubio-Navarro A, Sastre C, Blanco-Colio LM, Gómez-Guerrero C, Ortiz A, Egido J. Moreno JA, et al. Among authors: gomez guerrero c. Expert Opin Ther Targets. 2012 Aug;16(8):833-45. doi: 10.1517/14728222.2012.703657. Expert Opin Ther Targets. 2012. PMID: 22793382 Review.
Nephroprotective Effects of Synthetic Flavonoid Hidrosmin in Experimental Diabetic Nephropathy.
Jiménez-Castilla L, Marín-Royo G, Orejudo M, Opazo-Ríos L, Caro-Ordieres T, Artaiz I, Suárez-Cortés T, Zazpe A, Hernández G, Gómez-Guerrero C, Egido J. Jiménez-Castilla L, et al. Among authors: gomez guerrero c. Antioxidants (Basel). 2021 Nov 29;10(12):1920. doi: 10.3390/antiox10121920. Antioxidants (Basel). 2021. PMID: 34943023 Free PMC article.
Role of chemokines in proteinuric kidney disorders.
Moreno JA, Moreno S, Rubio-Navarro A, Gómez-Guerrero C, Ortiz A, Egido J. Moreno JA, et al. Among authors: gomez guerrero c. Expert Rev Mol Med. 2014 Feb 17;16:e3. doi: 10.1017/erm.2014.3. Expert Rev Mol Med. 2014. PMID: 24534600 Review.
The Coming Age of Flavonoids in the Treatment of Diabetic Complications.
Caro-Ordieres T, Marín-Royo G, Opazo-Ríos L, Jiménez-Castilla L, Moreno JA, Gómez-Guerrero C, Egido J. Caro-Ordieres T, et al. Among authors: gomez guerrero c. J Clin Med. 2020 Jan 27;9(2):346. doi: 10.3390/jcm9020346. J Clin Med. 2020. PMID: 32012726 Free PMC article. Review.
Proteomics in atherothrombosis: a future perspective.
Martín-Ventura JL, Blanco-Colio LM, Tunon J, Gomez-Guerrero C, Michel JB, Meilhac O, Egido J. Martín-Ventura JL, et al. Among authors: gomez guerrero c. Expert Rev Proteomics. 2007 Apr;4(2):249-60. doi: 10.1586/14789450.4.2.249. Expert Rev Proteomics. 2007. PMID: 17425460 Review.
69 results